|
SETD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.94539956261042E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.78475029094716E-12 |
| Normal-vs-Stage2 |
3.728000E-01 |
| Normal-vs-Stage3 |
1.41849865187282E-11 |
| Normal-vs-Stage4 |
1.81132886467594E-12 |
| Stage1-vs-Stage2 |
1.416600E-04 |
| Stage1-vs-Stage3 |
4.214800E-01 |
| Stage1-vs-Stage4 |
4.582300E-02 |
| Stage2-vs-Stage3 |
1.81039999999077E-05 |
| Stage2-vs-Stage4 |
1.76169999999143E-06 |
| Stage3-vs-Stage4 |
2.069200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.31477117660506E-14 |
| Normal-vs-AfricanAmerican |
1.98176999999244E-05 |
| Normal-vs-Asian |
1.59010005162941E-09 |
| Caucasian-vs-AfricanAmerican |
5.604000E-01 |
| Caucasian-vs-Asian |
9.346400E-01 |
| AfricanAmerican-vs-Asian |
6.087000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.26599841721031E-11 |
| Normal-vs-Female |
1.19120269204132E-11 |
| Male-vs-Female |
3.696800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.80311321429372E-12 |
| Normal-vs-Age(41-60Yrs) |
1.75899994570017E-09 |
| Normal-vs-Age(61-80Yrs) |
9.24950005476433E-09 |
| Normal-vs-Age(81-100Yrs) |
2.19670000001226E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.035600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.394000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.690600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.490800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.524620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.317980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.928480E-02 |
| Classical-VS-Follicular |
1.008500E-04 |
| Classical-VS-Other |
6.658000E-01 |
| Classical-VS-Normal |
7.30726590347786E-12 |
| Tall-VS-Follicular |
6.42239999959493E-07 |
| Tall-VS-Other |
5.986200E-01 |
| Tall-VS-Normal |
4.31432667369336E-13 |
| Follicular-VS-Other |
1.053220E-01 |
| Follicular-VS-Normal |
6.017900E-03 |
| Other-VS-Normal |
4.399800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.93970003895083E-09 |
| Normal-vs-N1 |
2.77555756156289E-15 |
| N0-vs-N1 |
3.93770000000071E-05 |
|
|
